Bio Medica Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	97.95	26.31	3.6	-	-
Depreciation & Amortization	10.05	11.1	4.97	-	-
Other Operating Activities	32.92	8.84	7.76	-	-
Change in Accounts Receivable	-17.64	17.37	13.74	-	-
Change in Inventory	-107.71	-34.65	-15.74	-	-
Change in Accounts Payable	22.53	-26.38	11.82	-	-
Change in Other Net Operating Assets	-74.82	-10.46	-19.63	-	-
Operating Cash Flow	-36.72	-7.88	6.52	-	-
Capital Expenditures	-0.19	-15.26	-17.1	-	-
Sale of Property, Plant & Equipment	0.46	-	-	-	-
Other Investing Activities	3.12	1.88	2.76	-	-
Investing Cash Flow	3.39	-13.38	-14.34	-	-
Short-Term Debt Issued	73	-	-	-	-
Long-Term Debt Issued	-	30.95	5.51	-	-
Total Debt Issued	73	30.95	5.51	-	-
Short-Term Debt Repaid	-17.75	-	-	-	-
Long-Term Debt Repaid	-10.01	-	-	-	-
Total Debt Repaid	-27.76	-	-	-	-
Net Debt Issued (Repaid)	45.24	30.95	5.51	-	-
Other Financing Activities	-11.95	-9.66	-7.74	-	-
Financing Cash Flow	33.29	21.29	-2.24	-	-
Miscellaneous Cash Flow Adjustments	-	-	-0.01	-	-
Net Cash Flow	-0.04	0.04	-10.07	-	-
Free Cash Flow	-36.91	-23.13	-10.58	-	-
Free Cash Flow Margin	-9.66%	-15.17%	-6.52%	-	-
Free Cash Flow Per Share	-4.02	-2.52	-1.15	-	-
Cash Interest Paid	11.95	9.66	7.74	-	-
Cash Income Tax Paid	12.48	-	-	-	-
Levered Free Cash Flow	-64.17	-13.73	0.13	-	-
Unlevered Free Cash Flow	-55.87	-7.86	4.69	-	-
Change in Working Capital	-177.64	-54.13	-9.81	-	-